Sunitinib in Certain Subtypes of Soft Tissue Sarcomas

Summary

The purpose of this study is to determine the clinical response rate (complete response and partial response) in patients with metastatic, locally advanced, or locally recurrent vascular soft tissue sarcoma treated with sunitinib.

Timeline

Start

2007-04

Primary completion

2012-11

Completion

2013-02

Outcome

Outcome not reported

Stopped: “Closed by pharmaceutical sponsor”

Drugs

Indications